Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet ROXIPER 20mg / 8mg / 2.5mg film-coated tablets
- Product code:
- W65530003
- Quantity:
- 30
- Indicated for:
- dyslipidemia
- Route of administration:
- oral
- Substance:
- rosuvastatin + perindopril + indapamide (statin lipid-lowering agent + ACE inhibitor + diuretic)
- ATC
- C10BX13 — Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Myopathy / rhabdomyolysis
Seek medical advice if unexplained muscle pain occurs.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
Rosuvastatin+perindopril+indapamide is a combination medication used for the treatment of dyslipidemia, hypertension, and the prevention of cardiovascular diseases. Rosuvastatin lowers LDL cholesterol and triglycerides, perindopril is an angiotensin-converting enzyme (ACE) inhibitor that reduces blood pressure, and indapamide is a thiazide diuretic that helps eliminate excess fluids and lower blood pressure.
This combination is taken orally, usually once daily, and is indicated for patients at high cardiovascular risk, including those with hypertension and associated dyslipidemia. It is commonly used to reduce the risk of major cardiovascular events such as myocardial infarction and stroke.
Common side effects include dizziness, nausea, muscle pain, and fatigue. In rare cases, severe adverse reactions such as kidney failure, hyperkalemia, or rhabdomyolysis may occur. Regular monitoring of renal function, blood pressure, and lipid profile is essential.
Rosuvastatin+perindopril+indapamide is a comprehensive therapeutic option for patients with multiple cardiovascular risk factors, offering significant benefits in a single administration.
This combination is taken orally, usually once daily, and is indicated for patients at high cardiovascular risk, including those with hypertension and associated dyslipidemia. It is commonly used to reduce the risk of major cardiovascular events such as myocardial infarction and stroke.
Common side effects include dizziness, nausea, muscle pain, and fatigue. In rare cases, severe adverse reactions such as kidney failure, hyperkalemia, or rhabdomyolysis may occur. Regular monitoring of renal function, blood pressure, and lipid profile is essential.
Rosuvastatin+perindopril+indapamide is a comprehensive therapeutic option for patients with multiple cardiovascular risk factors, offering significant benefits in a single administration.
General data about ROXIPER 20mg / 8mg / 2.5mg
- Substance:
- rosuvastatin + perindopril + indapamide
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65530003
- Concentration:
- 20mg / 8mg / 2.5mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 59.02 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for rosuvastatin + perindopril + indapamide
- 10mg/4mg/1.25mg
- 10mg/8mg/2.5mg
- 20mg/4mg/1.25mg
- 20mg/8mg/2.5mg
Compensation lists for ROXIPER 20mg / 8mg / 2.5mg KRKA
B - Sublist B with 50% discount from the reference price
- Price
- 59.02 RON
- Copayment
- 28.83 RON
- Patient
- 30.19 RON